Back
Conagra Brands 10K Form
Sell
20
CAG
Conagra Brands
Last Price:
$19.00
Seasonality Move:
1.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-04 | 10Q | CAG/Conagra Brands Quarterly |
2024-01-04 | 10Q | CAG/Conagra Brands Quarterly |
2023-10-05 | 10Q | CAG/Conagra Brands Quarterly |
2023-07-13 | 10K | CAG/Conagra Brands Annual |
2023-04-05 | 10Q | CAG/Conagra Brands Quarterly |
2023-01-05 | 10Q | CAG/Conagra Brands Quarterly |
Receive CAG News And Ratings
See the #1 stock for the next 7 days that we like better than CAG
CAG Financial Statistics
Sales & Book Value
Annual Sales: | $11.6B |
---|---|
Cash Flow: | $260.6M |
Price / Cash Flow: | 7.14 |
Annual Sales: | $18.71 |
Price / Book: | 1.04 |
Profitability
EPS (TTM): | 2.39000 |
---|---|
Net Income (TTM): | $1.2B |
Gross Margin: | $3B |
Return on Equity: | 13.18% |
Return on Assets: | 5.5% |
Conagra Brands Earnings Forecast
Key Conagra Brands Financial Ratios
-
The Gross Profit Margin over the past 42 years for CAG is 25.86%.
-
The Selling, General & Administrative Expenses for CAG have been equal to 13.24% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 36.38% of Operating Income.
-
The Net Earning history of CAG is 9.92% of Total Revenues.
-
Per Share Earnings over the last 42 years have been positive in 25 years.
Conagra Brands Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Food Products |
Sector: | Consumer Staples |
Current Symbol: | CAG |
CUSIP: | 205887 |
Website: | conagrabrands.com |
Debt
Debt-to-Equity Ratio: | 0.9 |
---|---|
Current Ratio: | 0.71 |
Quick Ratio: | 0.19 |
Price-to-Earnings
Trailing P/E Ratio: | 8.08 |
---|---|
Forward P/E Ratio: | 9.86 |
CAG Technical Analysis vs Fundamental Analysis
Sell
20
Conagra Brands (CAG)
is a Sell
Is Conagra Brands a Buy or a Sell?
-
Conagra Brands stock is rated a SellThe current Conagra Brands [CAG] share price is $19.38. The Score for CAG is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.